Clal Biotechnology | CBI - Pre Tax Profit


Clal Biotechnology reported ILS86.82M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.





Pre Tax Profit Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -4.6M 1.74M Jun/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
RedHill Biopharma USD -1.54M 12M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024